Skip to main content

Genomics England appoints Professor Matthew Hurles as Non-Executive Director

Genomics England has appointed Professor Matthew Hurles as a Non-Executive Director, bringing extensive scientific and strategic expertise to the Board. 

Professor Hurles is Director of the Wellcome Sanger Institute, where he also leads a research group investigating the genetic causes of severe developmental disorders and how DNA changes between generations. 

Professor Hurles established his research group at the Wellcome Sanger Institute in 2003, before being appointed as the fourth Director of the Institute in 2023.  

He co-leads the Deciphering Developmental Disorders Study, a collaboration between almost 14,000 families with children with severe, undiagnosed developmental disorders, all 24 clinical genetic centres in the UK and Ireland, and the Wellcome Sanger Institute. The study aims to improve diagnosis and care for children with developmental disorders through genetic testing, while exploring the ethical questions it raises.  

He was also the scientific lead of DECIPHER, an international project that links genetic and other types of data from people with rare genetic conditions. 

In addition to his work at the Wellcome Sanger Institute, Professor Hurles co-founded a start-up company, Congenica, to develop software to provide sustainable genetic diagnostic services to healthcare providers. 

In 2017, he was elected as a Fellow of the Academy of Medical Sciences, and in 2019, he was elected as a Fellow of the Royal Society. He has held numerous strategic advisory roles across the health and scientific sectors, advising AstraZeneca, the Medical Research Council, the Office of Life Sciences and UK Biobank on genomics. 

“We are delighted by Matt’s arrival and the considerable experience in genomic leadership that he brings. His expertise will be invaluable as we work with our partners to transform healthcare through genomics - building the evidence to support earlier diagnoses, more targeted treatments and new opportunities to prevent illness.”

Baroness Nicola Blackwood

Chair of Genomics England

“I’m thrilled to be joining the Board of Genomics England, having followed its innovative research for many years and seen the difference it has made for patients and participants. I look forward to contributing my experience and working with fellow Board members to help turn genomic advances into meaningful benefits for patients and families.” 

Professor Matthew Hurles

Media contact

[email protected]

Follow us